US Cancer Drug Approvals Ensure Access but Not Value

Cancer drugs that have been approved in the United States are often not immediately approved in the United Kingdom and Canada, owing to uncertainty over benefits and harms as well as extremely high prices, two new studies in JAMA Internal Medicine indicate. The oncology drug approval process of the US Food and Drug Administration (FDA) is “broken,” concludes an accompanying […]
» Read more